홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Dimethylformamide → 7-[2-(2-Formamidothiazol-4-yl)-2-cyanomethoxyiminoacetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid

HRID 255755
노트
인쇄 미리보기

반응식

HRID 255755 반응식
P(Cl)(Cl)(Cl)=O.CN(C)C=O.[CH:11]([NH:13][C:14]1[S:15][CH:16]=[C:17]([C:19](=[N:23][O:24][CH2:25][C:26](=O)[NH2:27])[C:20]([OH:22])=O)[N:18]=1)=[O:12].[NH2:29][CH:30]1[C:47](=[O:48])[N:32]2[C:33]([C:44]([OH:46])=[O:45])=[C:34]([CH2:37][S:38][C:39]3[S:40][CH:41]=[N:42][N:43]=3)[CH2:35][S:36][C@H:31]12>CC(C)=O.C(N(CC)CC)C.O1CCCC1>[CH:11]([NH:13][C:14]1[S:15][CH:16]=[C:17]([C:19](=[N:23][O:24][CH2:25][C:26]#[N:27])[C:20]([NH:29][CH:30]2[C:47](=[O:48])[N:32]3[C:33]([C:44]([OH:46])=[O:45])=[C:34]([CH2:37][S:38][C:39]4[S:40][CH:41]=[N:42][N:43]=4)[CH2:35][S:36][C@H:31]23)=[O:22])[N:18]=1)=[O:12]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 6228DimethylformamideHCID 24813Phosphorus oxychlorideHCID 128891877-Amino-3-(1,3,4-thiadiazol-2-ylthiomethyl)-3cephem-4-carboxylic acidHCID 538052302-(2-Formamidothiazol-4-yl)-2-carbamoylmethoxyiminoacetic acid

생성물 1

HCID 1317152817-[2-(2-Formamidothiazol-4-yl)-2-cyanomethoxyiminoacetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid
수율 34.8%

시약·촉매·용매 3

HCID 180Acetone용매HCID 8028Tetrahydrofuran용매HCID 8471Triethylamine용매

실험 절차

Phosphoryl chloride (0.96 g.), N,N-dimethylformamide (0.459 g.), tetrahydrofuran (12 ml.) and 2-(2-formamidothiazol-4-yl)-2-carbamoylmethoxyiminoacetic acid (syn isomer, 1.2 g.) were treated in a similar manner to that of Example 1-(1) to give an activated acid solution. After a suspension of 7-amino-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid (1.75 g.) in 50% aqueous acetone (16 ml.) was adjusted to pH 7 to 8.5 with triethylamine, the activated acid solution was added to the stirred solution at -5° to 0° C. while keeping at pH 6.5 to 7.5 and stirred at the same temperature for 30 minutes. After removing the solvent from the resultant solution in vacuo, ethyl acetate was added to the residue. The solution was adjusted to pH 1.5 with 10% hydrochloric acid and the insoluble substance was filtered off. The filtrate was extracted with ethyl acetate. The extract was washed with a saturated aqueous solution of sodium chloride, dried over magnesium sulfate and concentrated in vacuo. The residue was pulverized with diethyl ether to give 7-[2-(2-formamidothiazol-4-yl)-2-cyanomethoxyiminoacetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer, 0.87 g.).

후처리

  1. customto give an activated acid solution
  2. additionthe activated acid solution was added to the stirred solution at -5° to 0° C.
  3. customAfter removing the solvent from the resultant solution in vacuo, ethyl acetate
  4. additionwas added to the residue
  5. filtrationthe insoluble substance was filtered off
  6. extractionThe filtrate was extracted with ethyl acetate
  7. washThe extract was washed with a saturated aqueous solution of sodium chloride
  8. dry with materialdried over magnesium sulfate
  9. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-cbc6549da07743cea36d49f9ada22982
출처 데이터셋
uspto-grants-1987_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04698337

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트